ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,550,719 | -37.4% | 100,422 | 0.0% | 0.10% | -37.0% |
Q4 2022 | $4,073,116 | -21.4% | 100,422 | -36.0% | 0.15% | -27.4% |
Q3 2022 | $5,185,000 | -6.1% | 156,875 | 0.0% | 0.21% | -2.3% |
Q2 2022 | $5,524,000 | -10.9% | 156,875 | +16.4% | 0.22% | -0.5% |
Q1 2022 | $6,200,000 | -30.6% | 134,812 | 0.0% | 0.22% | -24.3% |
Q4 2021 | $8,938,000 | -29.9% | 134,812 | -34.0% | 0.29% | -29.9% |
Q3 2021 | $12,749,000 | +15.8% | 204,214 | +53.7% | 0.41% | +14.8% |
Q2 2021 | $11,006,000 | +24.9% | 132,886 | 0.0% | 0.36% | +18.2% |
Q1 2021 | $8,812,000 | -13.6% | 132,886 | 0.0% | 0.30% | -15.4% |
Q4 2020 | $10,196,000 | +219.2% | 132,886 | +79.1% | 0.36% | +198.3% |
Q3 2020 | $3,194,000 | -0.3% | 74,186 | 0.0% | 0.12% | -1.6% |
Q2 2020 | $3,204,000 | +50.1% | 74,186 | 0.0% | 0.12% | +27.1% |
Q1 2020 | $2,134,000 | -68.1% | 74,186 | -29.6% | 0.10% | -62.1% |
Q4 2019 | $6,685,000 | +672.8% | 105,398 | +243.3% | 0.25% | +565.8% |
Q3 2019 | $865,000 | +6.3% | 30,700 | 0.0% | 0.04% | +15.2% |
Q2 2019 | $814,000 | +44.6% | 30,700 | 0.0% | 0.03% | +43.5% |
Q1 2019 | $563,000 | +47.8% | 30,700 | 0.0% | 0.02% | +43.8% |
Q4 2018 | $381,000 | – | 30,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |